Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS.

Lopez-Chiriboga S, Pittock SJ, Weinshenker BG, Chen JJ, Flanagan E.

Mult Scler Relat Disord. 2019 Jun 29;35:34-35. doi: 10.1016/j.msard.2019.06.037. [Epub ahead of print] No abstract available.

PMID:
31299419
2.

Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis.

Mandel-Brehm C, Dubey D, Kryzer TJ, O'Donovan BD, Tran B, Vazquez SE, Sample HA, Zorn KC, Khan LM, Bledsoe IO, McKeon A, Pleasure SJ, Lennon VA, DeRisi JL, Wilson MR, Pittock SJ.

N Engl J Med. 2019 Jul 4;381(1):47-54. doi: 10.1056/NEJMoa1816721.

PMID:
31269365
3.

Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology.

Sechi E, Shosha E, Williams JP, Pittock SJ, Weinshenker BG, Keegan BM, Zalewski NL, Lopez-Chiriboga AS, Jitprapaikulsan J, Flanagan EP.

Neurology. 2019 Jun 24. pii: 10.1212/WNL.0000000000007828. doi: 10.1212/WNL.0000000000007828. [Epub ahead of print]

PMID:
31235660
4.

GABAA receptor autoimmunity: A multicenter experience.

O'Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 4;6(3):e552. doi: 10.1212/NXI.0000000000000552. eCollection 2019 May.

5.

Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up.

Petzold A, Woodhall M, Khaleeli Z, Tobin WO, Pittock SJ, Weinshenker BG, Vincent A, Waters P, Plant GT.

J Neurol Neurosurg Psychiatry. 2019 May 22. pii: jnnp-2019-320493. doi: 10.1136/jnnp-2019-320493. [Epub ahead of print]

PMID:
31118222
6.

Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.

Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, Nakashima I, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Fujita KP, Armstrong R, Wingerchuk DM.

N Engl J Med. 2019 May 3. doi: 10.1056/NEJMoa1900866. [Epub ahead of print]

PMID:
31050279
7.

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.

Palace J, Lin DY, Zeng D, Majed M, Elsone L, Hamid S, Messina S, Misu T, Sagen J, Whittam D, Takai Y, Leite MI, Weinshenker B, Cabre P, Jacob A, Nakashima I, Fujihara K, Pittock SJ.

Brain. 2019 May 1;142(5):1310-1323. doi: 10.1093/brain/awz054.

8.

Isolated recurrent myelitis in a persistent MOG positive patient.

Anis S, Regev K, Pittock SJ, Flanagan EP, Alcalay Y, Gadoth A.

Mult Scler Relat Disord. 2019 May;30:163-164. doi: 10.1016/j.msard.2019.02.016. Epub 2019 Feb 13.

PMID:
30780123
9.

A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis.

Taraschenko O, Fox HS, Pittock SJ, Zekeridou A, Gafurova M, Eldridge E, Liu J, Dravid SM, Dingledine R.

Epilepsia. 2019 Mar;60(3):452-463. doi: 10.1111/epi.14662. Epub 2019 Feb 11.

PMID:
30740690
10.

A multicenter comparison of MOG-IgG cell-based assays.

Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, Mills J, Flanagan EP, Irani SR, Kunchok AC, McKeon A, Pittock SJ.

Neurology. 2019 Mar 12;92(11):e1250-e1255. doi: 10.1212/WNL.0000000000007096. Epub 2019 Feb 6.

11.

Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability.

Dubey D, Pittock SJ, McKeon A.

Epilepsia. 2019 Feb;60(2):367-369. doi: 10.1111/epi.14649. No abstract available.

PMID:
30727035
12.

Optical coherence tomography is highly sensitive in detecting prior optic neuritis.

Xu SC, Kardon RH, Leavitt JA, Flanagan EP, Pittock SJ, Chen JJ.

Neurology. 2019 Feb 5;92(6):e527-e535. doi: 10.1212/WNL.0000000000006873. Epub 2019 Jan 23.

PMID:
30674600
13.

Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.

Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP.

JAMA Neurol. 2018 Dec 21. doi: 10.1001/jamaneurol.2018.4053. [Epub ahead of print]

PMID:
30575890
14.

Age is a critical determinant in recovery from multiple sclerosis relapses.

Conway BL, Zeydan B, Uygunoğlu U, Novotna M, Siva A, Pittock SJ, Atkinson EJ, Rodriguez M, Kantarci OH.

Mult Scler. 2018 Oct 10:1352458518800815. doi: 10.1177/1352458518800815. [Epub ahead of print]

PMID:
30303037
15.

Paraneoplastic neuronal intermediate filament autoimmunity.

Basal E, Zalewski N, Kryzer TJ, Hinson SR, Guo Y, Dubey D, Benarroch EE, Lucchinetti CF, Pittock SJ, Lennon VA, McKeon A.

Neurology. 2018 Oct 30;91(18):e1677-e1689. doi: 10.1212/WNL.0000000000006435. Epub 2018 Oct 3.

16.

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD.

Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ.

Neurology. 2018 Oct 23;91(17):e1642-e1651. doi: 10.1212/WNL.0000000000006392. Epub 2018 Sep 26.

17.

Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies.

Xu M, Bennett DLH, Querol LA, Wu LJ, Irani SR, Watson JC, Pittock SJ, Klein CJ.

J Neurol Neurosurg Psychiatry. 2018 Sep 17. pii: jnnp-2018-318556. doi: 10.1136/jnnp-2018-318556. [Epub ahead of print]

PMID:
30224548
18.

Population-based study of "no evident disease activity" in MS.

Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 16;5(6):e495. doi: 10.1212/NXI.0000000000000495. eCollection 2018 Nov.

19.

Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction.

Dubey D, Kothapalli N, McKeon A, Flanagan EP, Lennon VA, Klein CJ, Britton JW, So E, Boeve BF, Tillema JM, Sadjadi R, Pittock SJ.

J Neuroimmunol. 2018 Oct 15;323:62-72. doi: 10.1016/j.jneuroim.2018.07.009. Epub 2018 Jul 25.

PMID:
30196836
20.

Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1.

Feyissa AM, Lamb C, Pittock SJ, Gadoth A, McKeon A, Klein CJ, Britton JW.

Epilepsia Open. 2018 Jun 25;3(3):348-356. doi: 10.1002/epi4.12226. eCollection 2018 Sep.

21.

Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1.

Mammen AL, Rajan A, Pak K, Lehky T, Casciola-Rosen L, Donahue RN, Lepone LM, Zekeridou A, Pittock SJ, Hassan R, Schlom J, Gulley JL.

Ann Rheum Dis. 2019 Jan;78(1):150-152. doi: 10.1136/annrheumdis-2018-213777. Epub 2018 Sep 5. No abstract available.

PMID:
30185415
22.

Posttransplant autoimmune encephalitis.

Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, Hogan WJ, Poterucha JJ, Wilton KM, Lin Y, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 20;5(6):e497. doi: 10.1212/NXI.0000000000000497. eCollection 2018 Nov. No abstract available.

23.

LGI1 and CASPR2 neurological autoimmunity in children.

López-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Aaen JG, Brenton JN, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ.

Ann Neurol. 2018 Sep;84(3):473-480. doi: 10.1002/ana.25310.

PMID:
30076629
24.

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.

Am J Ophthalmol. 2018 Nov;195:8-15. doi: 10.1016/j.ajo.2018.07.020. Epub 2018 Jul 26.

25.

Spontaneous posterior spinal artery infarction: An under-recognized cause of acute myelopathy.

Zalewski NL, Rabinstein AA, Wijdicks EFM, Petty GW, Pittock SJ, Mantyh WG, Flanagan EP.

Neurology. 2018 Aug 28;91(9):414-417. doi: 10.1212/WNL.0000000000006084. Epub 2018 Jul 25. No abstract available.

PMID:
30045962
26.

Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis.

Sechi E, Morris PP, McKeon A, Pittock SJ, Hinson SR, Weinshenker BG, Aksamit AJ, Krecke KN, Kaufmann TJ, Jolliffe EA, Zalewski NL, Zekeridou A, Wingerchuk DM, Jitprapaikulsan J, Flanagan EP.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):488-490. doi: 10.1136/jnnp-2018-318004. Epub 2018 Jul 21. No abstract available.

PMID:
30032117
27.

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.

López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ.

JAMA Neurol. 2018 Nov 1;75(11):1355-1363. doi: 10.1001/jamaneurol.2018.1814.

28.

Autoimmune septin-5 cerebellar ataxia.

Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Fryer JP, Devine M, Flores A, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 9;5(5):e474. doi: 10.1212/NXI.0000000000000474. eCollection 2018 Sep. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2018 Dec 12;6(1):e534.

29.

Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year.

Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A.

J Neuroimmunol. 2018 Aug 15;321:157-163. doi: 10.1016/j.jneuroim.2018.04.016. Epub 2018 Apr 27.

PMID:
29793728
30.

Elevated LGI1-IgG CSF index predicts worse neurological outcome.

Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ.

Ann Clin Transl Neurol. 2018 Apr 2;5(5):646-650. doi: 10.1002/acn3.561. eCollection 2018 May.

31.

Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.

Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ.

Ophthalmology. 2018 Oct;125(10):1628-1637. doi: 10.1016/j.ophtha.2018.03.041. Epub 2018 Apr 30.

PMID:
29716788
32.

Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis.

Jitprapaikulsan J, Lopez Chiriboga AS, Flanagan EP, Fryer JP, McKeon A, Weinshenker BG, Pittock SJ.

JAMA Neurol. 2018 Jul 1;75(7):892-895. doi: 10.1001/jamaneurol.2018.0805. No abstract available.

33.

Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.

Guerra H, Pittock SJ, Moder KG, Fryer JP, Gadoth A, Flanagan EP.

Mayo Clin Proc. 2018 Sep;93(9):1299-1304. doi: 10.1016/j.mayocp.2018.02.006. Epub 2018 Apr 11.

PMID:
29655487
34.

Reply to "epidemiology of autoimmune versus infectious encephalitis".

Dubey D, Pittock SJ, Toledano M, Flanagan EP.

Ann Neurol. 2018 May;83(5):1038. doi: 10.1002/ana.25230. No abstract available.

PMID:
29637594
35.

GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.

Liimatainen S, Honnorat J, Pittock SJ, McKeon A, Manto M, Radtke JR; T1D Exchange Biobank, Hampe CS.

Orphanet J Rare Dis. 2018 Apr 10;13(1):55. doi: 10.1186/s13023-018-0787-5.

36.

Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.

Chen JJ, Tobin WO, Majed M, Jitprapaikulsan J, Fryer JP, Leavitt JA, Flanagan EP, McKeon A, Pittock SJ.

JAMA Ophthalmol. 2018 Apr 1;136(4):419-422. doi: 10.1001/jamaophthalmol.2017.6757.

37.

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.

Hinson SR, Lopez-Chiriboga AS, Bower JH, Matsumoto JY, Hassan A, Basal E, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 23;5(2):e438. doi: 10.1212/NXI.0000000000000438. eCollection 2018 Mar.

38.

CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.

Gurtner KM, Shosha E, Bryant SC, Andreguetto BD, Murray DL, Pittock SJ, Willrich MAV.

Clin Chem Lab Med. 2018 Jun 27;56(7):1071-1080. doi: 10.1515/cclm-2017-0901.

39.

ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association.

Alfugham N, Gadoth A, Lennon VA, Komorowski L, Scharf M, Hinson S, McKeon A, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 8;5(1):e418. doi: 10.1212/NXI.0000000000000418. eCollection 2018 Jan. No abstract available.

40.

MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy.

Fredriksen JR, Carr CM, Koeller KK, Verdoorn JT, Gadoth A, Pittock SJ, Kotsenas AL.

Neuroradiology. 2018 Mar;60(3):239-245. doi: 10.1007/s00234-018-1976-6. Epub 2018 Jan 20.

PMID:
29353399
41.

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.

Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP.

Ann Neurol. 2018 Jan;83(1):166-177. doi: 10.1002/ana.25131.

42.

Calcium channel autoimmunity: Cerebellar ataxia and lambert-eaton syndrome coexisting.

Zalewski N, Lennon VA, Pittock SJ, Mckeon A.

Muscle Nerve. 2017 Dec 22. doi: 10.1002/mus.26053. [Epub ahead of print]

PMID:
29272039
43.

Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM.

Martinez-Thompson JM, Snyder MR, Ettore M, McKeon A, Pittock SJ, Roforth MM, Mandrekar J, Mauermann ML, Taylor BV, Dyck PJB, Windebank AJ, Klein CJ.

Muscle Nerve. 2018 Jun;57(6):1000-1005. doi: 10.1002/mus.26051. Epub 2018 Jan 26.

PMID:
29272035
44.

Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.

Dubey D, Lennon VA, Gadoth A, Pittock SJ, Flanagan EP, Schmeling JE, McKeon A, Klein CJ.

Neurology. 2018 Jan 9;90(2):e103-e110. doi: 10.1212/WNL.0000000000004803. Epub 2017 Dec 8.

PMID:
29222126
45.

Optic Disc Edema in Glial Fibrillary Acidic Protein Autoantibody-Positive Meningoencephalitis.

Chen JJ, Aksamit AJ, McKeon A, Pittock SJ, Weinshenker BG, Leavitt JA, Morris PP, Flanagan EP.

J Neuroophthalmol. 2018 Sep;38(3):276-281. doi: 10.1097/WNO.0000000000000593.

PMID:
29210929
46.

Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management.

Shosha E, Pittock SJ, Flanagan E, Weinshenker BG.

Mult Scler. 2017 Dec;23(14):1808-1817. doi: 10.1177/1352458517740215. Review.

PMID:
29154728
47.

Purkinje cell cytoplasmic antibody type I (anti-Yo): predictive of gastrointestinal adenocarcinomas in men.

Linnoila J, Guo Y, Gadoth A, Raghunathan A, Parks B, McKeon A, Lucchinetti CF, Lennon VA, Pittock SJ.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1116-1117. doi: 10.1136/jnnp-2017-316829. Epub 2017 Nov 15. No abstract available.

PMID:
29142142
48.

Breast cancer-related paraneoplastic neurologic disease.

Murphy BL, Zalewski NL, Degnim AC, McKeon A, Flanagan EP, Pittock SJ, Habermann EB.

Breast Cancer Res Treat. 2018 Feb;167(3):771-778. doi: 10.1007/s10549-017-4566-0. Epub 2017 Nov 7.

PMID:
29116466
49.

B-cell-targeted therapies in relapsing forms of MS.

Dubey D, Forsthuber T, Flanagan EP, Pittock SJ, Stüve O.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 23;4(6):e405. doi: 10.1212/NXI.0000000000000405. eCollection 2017 Nov. Review.

50.

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.

Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):526-534. doi: 10.1136/jnnp-2017-315720. Epub 2017 Oct 21. Review.

Supplemental Content

Loading ...
Support Center